Warner-Lambert GMP Conviction Plays Role In Neurontin Case

Warner-Lambert's 1995 guilty plea related to good manufacturing practices compliance is an important factor in the Neurontin off-label promotion case settled by Pfizer on May 13

More from Archive

More from Pink Sheet